Literature DB >> 19208869

Age-related macular degeneration.

Tariq Ayoub1, Nishal Patel.   

Abstract

Mesh：

Year:  2009        PMID： 19208869      PMCID： PMC2642874          DOI： 10.1258/jrsm.2009.080298

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  45 in total

1.  In vivo demonstration of the anatomic differences between classic and occult choroidal neovascularization using optical coherence tomography.

Authors:  Edward H Hughes; Jaheed Khan; Nishal Patel; Shahram Kashani; N Victor Chong
Journal:  Am J Ophthalmol       Date:  2005-02       Impact factor: 5.258

2.  Complement factor H polymorphism in age-related macular degeneration.

Authors:  Robert J Klein; Caroline Zeiss; Emily Y Chew; Jen-Yue Tsai; Richard S Sackler; Chad Haynes; Alice K Henning; John Paul SanGiovanni; Shrikant M Mane; Susan T Mayne; Michael B Bracken; Frederick L Ferris; Jurg Ott; Colin Barnstable; Josephine Hoh
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

3.  Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1991-08

4.  Regression of experimental iris neovascularization with systemic alpha-interferon.

Authors:  J W Miller; W G Stinson; J Folkman
Journal:  Ophthalmology       Date:  1993-01       Impact factor: 12.079

5.  Complement factor H polymorphism and age-related macular degeneration.

Authors:  Albert O Edwards; Robert Ritter; Kenneth J Abel; Alisa Manning; Carolien Panhuysen; Lindsay A Farrer
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

6.  Complement factor H variant increases the risk of age-related macular degeneration.

Authors:  Jonathan L Haines; Michael A Hauser; Silke Schmidt; William K Scott; Lana M Olson; Paul Gallins; Kylee L Spencer; Shu Ying Kwan; Maher Noureddine; John R Gilbert; Nathalie Schnetz-Boutaud; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

7.  Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III.

Authors:  R Klein; B E Klein; S C Jensen; J A Mares-Perlman; K J Cruickshanks; M Palta
Journal:  Ophthalmology       Date:  1999-06       Impact factor: 12.079

Review 8.  Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration.

Authors:  Eugene W M Ng; Anthony P Adamis
Journal:  Can J Ophthalmol       Date:  2005-06       Impact factor: 1.882

9.  Pegaptanib for neovascular age-related macular degeneration.

Authors:  Evangelos S Gragoudas; Anthony P Adamis; Emmett T Cunningham; Matthew Feinsod; David R Guyer
Journal:  N Engl J Med       Date:  2004-12-30       Impact factor: 91.245

10.  Global data on visual impairment in the year 2002.

Authors:  Serge Resnikoff; Donatella Pascolini; Daniel Etya'ale; Ivo Kocur; Ramachandra Pararajasegaram; Gopal P Pokharel; Silvio P Mariotti
Journal:  Bull World Health Organ       Date:  2004-12-14       Impact factor: 9.408
View more
  15 in total

1.  Age-related macular degeneration and its effect on quality of life.

Authors:  Alexander Silvester
Journal:  J R Soc Med       Date:  2009-08       Impact factor: 5.344

2.  In Vivo Elasticity Mapping of Posterior Ocular Layers Using Acoustic Radiation Force Optical Coherence Elastography.

Authors:  Yueqiao Qu; Youmin He; Arya Saidi; Yihang Xin; Yongxiao Zhou; Jiang Zhu; Teng Ma; Ronald H Silverman; Don S Minckler; Qifa Zhou; Zhongping Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

3.  Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis.

Authors:  Aswani Dutt Vadlapudi; Ashaben Patel; Kishore Cholkar; Ashim K Mitra
Journal:  Recent Pat Biomed Eng       Date:  2012-04-01

Review 4.  Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.

Authors:  Ramya Krishna Vadlapatla; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Curr Drug Targets       Date:  2013-07       Impact factor: 3.465

5.  Statistical driver genes as a means to uncover missing heritability for age-related macular degeneration.

Authors:  Andrea R Waksmunski; Michelle Grunin; Tyler G Kinzy; Robert P Igo; Jonathan L Haines; Jessica N Cooke Bailey
Journal:  BMC Med Genomics       Date:  2020-07-06       Impact factor: 3.063

6.  Rare variants and loci for age-related macular degeneration in the Ohio and Indiana Amish.

Authors:  Andrea R Waksmunski; Robert P Igo; Yeunjoo E Song; Jessica N Cooke Bailey; Renee Laux; Denise Fuzzell; Sarada Fuzzell; Larry D Adams; Laura Caywood; Michael Prough; Dwight Stambolian; William K Scott; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Hum Genet       Date:  2019-07-31       Impact factor: 5.881

7.  The Interplay Between Systemic Inflammatory Factors and MicroRNAs in Age-Related Macular Degeneration.

Authors:  Zofia Litwińska; Anna Sobuś; Karolina Łuczkowska; Aleksandra Grabowicz; Katarzyna Mozolewska-Piotrowska; Krzysztof Safranow; Miłosz Piotr Kawa; Bogusław Machaliński; Anna Machalińska
Journal:  Front Aging Neurosci       Date:  2019-10-22       Impact factor: 5.750

Review 8.  Treatment Landscape of Macular Disorders in Indian Patients with the Advent of Razumab™ (World's First Biosimilar Ranibizumab): A Comprehensive Review.

Authors:  Shashikant Sharma; Tanishq Sharma; Somdutt Prasad; Mahesh Gopalakrishnan; Alok Chaturvedi
Journal:  Ophthalmol Ther       Date:  2021-06-21

9.  Pathway Analysis Integrating Genome-Wide and Functional Data Identifies PLCG2 as a Candidate Gene for Age-Related Macular Degeneration.

Authors:  Andrea R Waksmunski; Michelle Grunin; Tyler G Kinzy; Robert P Igo; Jonathan L Haines; Jessica N Cooke Bailey
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-09-03       Impact factor: 4.799

10.  A Multicenter, Retrospective Study (RE-ENACT 2) on the Use of Razumab™ (World's First Biosimilar Ranibizumab) in Wet Age-Related Macular Degeneration.

Authors:  Shashikant Sharma; Mujtaba Khan; Alok Chaturvedi
Journal:  Ophthalmol Ther       Date:  2019-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.